Praj's 2nd Generation Ethanol Technology - click to learn more


Iowa - just waiting for you - click here to learn more


Novozymes Fiberex, Innova Apex, Innova Turbo, click here to learn more


Topsoe - transform how the world looks at waste - click here to learn more


S&B Engineers - Consider it Done - Top Biofuels EPC - click here to learn more.


Convergence - A new ethanol fermentation platform of high performance yeast and enzymes, united - Lallemand Biofuels & Distilled Spirits - click here to learn more.


Enerkem - Building the Circular Economy - click to learn more


Clariant — Cellulosic ethanol from agricultural residues. Think Ahead. Think Sunliquid.

Tag: DSM Nutritional Products

Transform Materials achieves milestone in commercial-scale production plans

Transform Materials achieves milestone in commercial-scale production plans

May 16, 2021 |

In Florida, Transform Materials LLC, a chemical company with a patented net-carbon-negative process to cost-effectively produce commercial acetylene and hydrogen, reached a key milestone in scaling its global production capability. Transform and DSM Nutritional Products began discussions for global-scale commercial production. Transform in alignment with its licensing partner, DSM Nutritional Products Ltd, part of Netherlands-based […]

Read More

Amyris signs $500M deal with DSM Nutritional Products

Amyris signs $500M deal with DSM Nutritional Products

March 31, 2021 |

In California, Amyris, Inc. has signed and closed an agreement with DSM Nutritional Products Ltd., a subsidiary of Royal DSM for the exclusive rights to supply Amyris’s product portfolio of flavor and fragrance (F&F) ingredients. Amyris will continue to develop, scale and manufacture future molecules with its existing partners and DSM. The total transaction value […]

Read More

Amyris seals $50M deal with DSM Nutritional Products

Amyris seals $50M deal with DSM Nutritional Products

December 21, 2020 |

In California, Amyris announced the closing of a strategic transaction with DSM Nutritional Products Ltd., the first of three anticipated transactions management described during its recent virtual investor mini-series event, held on December 15, 2020. Under the terms of the agreement Amyris is licensing to DSM rights to assume the supply of Farnesene to Givaudan […]

Read More